Recombinant Human Follitropin (Beijing Shuanglu Pharmaceutical)
重组人促卵泡激素（北京双鹭药业）
Report date: 2026/03/30 20:02:02
Base Information
Drug NameRecombinant Human Follitropin (Beijing Shuanglu Pharmaceutical)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesBeijing Sl Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesBeijing Sl Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A